Literature DB >> 22872842

Outcome of management of local recurrence after immediate transverse rectus abdominis myocutaneous flap breast reconstruction.

Taik Jong Lee1, Wu Jin Hur, Eun Key Kim, Sei Hyun Ahn.   

Abstract

BACKGROUND: No consensus has been reached regarding the outcome of management of local recurrence after transverse rectus abdominis myocutaneous (TRAM) flap breast reconstruction. This study demonstrated the presentation, management, and outcomes of local recurrence after immediate TRAM breast reconstruction.
METHODS: A comparison was conducted among 1,000 consecutive patients who underwent immediate breast reconstruction with a pedicled TRAM flap (TRAM group) and 3,183 consecutive patients who underwent only modified radical mastectomy without reconstruction (MRM group) from January 2001 to December 2009. The presentation, treatment, and outcome including aesthetics and overall survival rate were analyzed.
RESULTS: Local recurrences occurred in 18 (1.8%) patients (TRAM-LR group) who underwent TRAM breast reconstruction and 38 (1.2%) patients (MRM-LR group) who underwent MRM only (P=0.1712). Wide excision was indicated in almost all the local recurrence cases. Skin graft was required in 4 patients in the MRM-LR group, whereas only one patient required a skin graft to preserve the mound shape in the TRAM-LR group. The breast mound was maintained in all 17 patients that survived in the TRAM-LR group even after wide excision. The overall survival rate was 94.4% in the TRAM-LR group and 65.8% in the MRM-LR group (P=0.276).
CONCLUSIONS: Local recurrence after immediate TRAM flap breast reconstruction could be detected without delay and managed effectively by multiple modalities without reducing overall survival rates. Breast mound reconstruction with soft autologous tissue allowed for primary closure in most of the cases. In all of the patients who survived, the contour of their reconstructed breast remained.

Entities:  

Keywords:  Breast neoplasms; Mammaplasty; Neoplasm recurrence, local

Year:  2012        PMID: 22872842      PMCID: PMC3408284          DOI: 10.5999/aps.2012.39.4.376

Source DB:  PubMed          Journal:  Arch Plast Surg        ISSN: 2234-6163


  12 in total

1.  Retrospective study of the skin-sparing mastectomy in breast reconstruction.

Authors:  B A Toth; B G Forley; R Calabria
Journal:  Plast Reconstr Surg       Date:  1999-07       Impact factor: 4.730

2.  Local recurrence risk after skin-sparing and conventional mastectomy: a 6-year follow-up.

Authors:  S S Kroll; A Khoo; S E Singletary; F C Ames; B G Wang; G P Reece; M J Miller; G R Evans; G L Robb
Journal:  Plast Reconstr Surg       Date:  1999-08       Impact factor: 4.730

3.  Breast cancer local recurrence after mastectomy and TRAM flap reconstruction: incidence and treatment options.

Authors:  Michael A Howard; Kristen Polo; Andrea L Pusic; Peter G Cordeiro; David A Hidalgo; Babak Mehrara; Joseph J Disa
Journal:  Plast Reconstr Surg       Date:  2006-04-15       Impact factor: 4.730

4.  Chronological changes of clinical characteristics in 31,115 new breast cancer patients among Koreans during 1996-2004.

Authors:  Sei Hyun Ahn; Keun Young Yoo
Journal:  Breast Cancer Res Treat       Date:  2006-03-16       Impact factor: 4.872

5.  Nipple areola skin-sparing mastectomy with immediate transverse rectus abdominis musculocutaneous flap reconstruction is an oncologically safe procedure: a single center study.

Authors:  Hee Jeong Kim; Eun Hwa Park; Woo Sung Lim; Jin Young Seo; Beom Suk Koh; Taik Jong Lee; Jin Sup Eom; Sung Wook Lee; Byung Ho Son; Jong Won Lee; Sei Hyun Ahn
Journal:  Ann Surg       Date:  2010-03       Impact factor: 12.969

6.  Skin-sparing mastectomy with conservation of the nipple-areola complex and autologous reconstruction is an oncologically safe procedure.

Authors:  Bernd Gerber; Annette Krause; Toralf Reimer; Heiner Müller; Ingrid Küchenmeister; Joseph Makovitzky; Günther Kundt; Klaus Friese
Journal:  Ann Surg       Date:  2003-07       Impact factor: 12.969

7.  Presentation, treatment, and outcome of local recurrence afterskin-sparing mastectomy and immediate breast reconstruction.

Authors:  L A Newman; H M Kuerer; K K Hunt; S S Kroll; F C Ames; M I Ross; B W Feig; S E Singletary
Journal:  Ann Surg Oncol       Date:  1998 Oct-Nov       Impact factor: 5.344

8.  Skin-sparing mastectomy and immediate autologous tissue reconstruction after whole-breast irradiation.

Authors:  Joseph J Disa; Peter G Cordeiro; Alexandra H Heerdt; Jeanne A Petrek; Patrick J Borgen; David A Hidalgo
Journal:  Plast Reconstr Surg       Date:  2003-01       Impact factor: 4.730

9.  Skin-sparing mastectomy and immediate breast reconstruction: a prospective cohort study for the treatment of advanced stages of breast carcinoma.

Authors:  Robert D Foster; Laura J Esserman; James P Anthony; Eun-sil S Hwang; Hoang Do
Journal:  Ann Surg Oncol       Date:  2002-06       Impact factor: 5.344

10.  The sooner the better: a study of psychological factors in women undergoing immediate versus delayed breast reconstruction.

Authors:  W S Schain; D K Wellisch; R O Pasnau; J Landsverk
Journal:  Am J Psychiatry       Date:  1985-01       Impact factor: 18.112

View more
  10 in total

1.  Local recurrence of breast cancer in reconstructed breasts using TRAM flap after skin-sparing mastectomy: clinical and imaging features.

Authors:  Hyunkyung Yoo; Bo Hyun Kim; Hak Hee Kim; Joo Hee Cha; Hee Jung Shin; Taik Jong Lee
Journal:  Eur Radiol       Date:  2014-05-24       Impact factor: 5.315

Review 2.  Multimodality Imaging of the Reconstructed Breast.

Authors:  Beatriz E Adrada; Gary J Whitman; Melissa A Crosby; Selin Carkaci; Mark J Dryden; Basak E Dogan
Journal:  Curr Probl Diagn Radiol       Date:  2015-04-27

3.  Current Trends in Prepectoral Breast Reconstruction: A Survey of American Society of Plastic Surgeons Members.

Authors:  Jacob M Marks; Rebecca L Farmer; Ahmed M Afifi
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-08-19

4.  Is There a Difference in the Diagnosis and Prognosis of Local Recurrence between Autologous Tissue and Implant-Based Breast Reconstruction?

Authors:  Kyunghyun Min; Hyun Ho Han; Eun Key Kim; Sae Byul Lee; Jisun Kim; Il Yong Chung; Hee Jeong Kim; Beom Seok Ko; Jong Won Lee; Byung Ho Son; Sei Hyun Ahn; Jin Sup Eom
Journal:  Breast J       Date:  2022-04-11       Impact factor: 2.269

5.  Reconstruction of Unexpected Huge Chest Wall Defect after Recurrent Breast Cancer Excision Using a TRAM Flap Combined with Partial Latissimus Dorsi Muscle Flap.

Authors:  Jae A Jung; Yang Woo Kim; So Ra Kang
Journal:  Arch Plast Surg       Date:  2013-01-14

6.  The prognosis of breast cancer patients after mastectomy and immediate breast reconstruction: a meta-analysis.

Authors:  Xue Yang; Chenfang Zhu; Yan Gu
Journal:  PLoS One       Date:  2015-05-29       Impact factor: 3.240

7.  Local recurrence following mastectomy and autologous breast reconstruction: incidence, risk factors, and management.

Authors:  Siyu Wu; Miao Mo; Yujie Wang; Na Zhang; Jianwei Li; Genhong Di; Zhimin Shao; Jiong Wu; Guangyu Liu
Journal:  Onco Targets Ther       Date:  2016-11-04       Impact factor: 4.147

8.  Breast cancer recurrence after immediate and delayed postmastectomy breast reconstruction-A systematic review and meta-analysis.

Authors:  Claudia A Bargon; Danny A Young-Afat; Mehmet Ikinci; Assa Braakenburg; Hinne A Rakhorst; Marc A M Mureau; Helena M Verkooijen; Annemiek Doeksen
Journal:  Cancer       Date:  2022-07-27       Impact factor: 6.921

9.  Long-term outcomes of immediate autologous breast reconstruction after definite adjuvant therapy in intermediate and locally advanced breast cancer.

Authors:  Won Sup Yoon; Chai Hong Rim; Dae Sik Yang; Jung Ae Lee; Gil Soo Son; Young Woo Chang; Sang Uk Woo; Deok-Woo Kim; Eun-Sang Dhong
Journal:  Ann Transl Med       Date:  2019-12

10.  Oncologic Safety of Immediate Breast Reconstruction for Invasive Breast Cancer Patients: A Matched Case Control Study.

Authors:  Shin-Hoo Park; Wonshik Han; Tae-Kyung Yoo; Han-Byoel Lee; Ung Sik Jin; Hak Chang; Kyung Won Minn; Dong-Young Noh
Journal:  J Breast Cancer       Date:  2016-03-25       Impact factor: 3.588

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.